TransCode Therapeutics, Inc. Announces Closing of Registered Direct Offering
BOSTON, March 25, 2025 /PRNewswire/ — TransCode Therapeutics, Inc. (Nasdaq: RNAZ), (“TransCode” or the “Company”), the RNA oncology... Read more.
General Dynamics Electric Boat awarded $1 billion contract modification for long lead time material for Virginia-class submarines
GROTON, Conn., March 25, 2025 /PRNewswire/ — General Dynamics Electric Boat, a business unit of General Dynamics (NYSE: GD), announced today it has been awarded... Read more.
Solventum partners with SprintRay to disrupt the digital dentistry market with high-quality, permanent same-day restorations
In this first-of-its-kind partnership for its Dental Solutions business, Solventum, formerly 3M Health Care, is striving to focus on longevity and durability of... Read more.
Mission Wealth Named to InvestmentNews’ 2025 Best Places to Work for Financial Advisors
SANTA BARBARA, Calif., March 25, 2025 /PRNewswire/ — Mission Wealth is proud to announce it has been named to the 2025 InvestmentNews Best Places to Work... Read more.
NASA Invites Media to Learn About Artemis Moon Mission Recovery
WASHINGTON, March 25, 2025 /PRNewswire/ — NASA and the Department of Defense will host a media event on the recovery operations that will bring the Artemis... Read more.
ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research Annual Meeting 2025
Oral presentation to highlight preclinical investigation of Claudin-6 ADC in ovarian and NSCLC cancer models Preclinical data for PSMA and ASCT2-targeted ADCs accepted... Read more.
Purelight Power Expands to Minneapolis, Making Solar Energy More Affordable for Homeowners
MINNEAPOLIS, March 25, 2025 /PRNewswire/ — Purelight Power, a top provider of residential solar solutions, is excited to announce its expansion into Minneapolis.... Read more.
EPSIUM ENTERPRISE LIMITED Announces Pricing of US$5.0 Million Initial Public Offering
MACAU, March 25, 2025 /PRNewswire/ — EPSIUM ENTERPRISE LIMITED (the “Company” or “EPSIUM”), a company engaged in importing and wholesaling... Read more.
Nuvalent to Present New Preclinical Data on ALK-Selective Inhibitor, Neladalkib, and ROS1-Selective Inhibitor, Zidesamtinib, at AACR Annual Meeting 2025
CAMBRIDGE, Mass., March 25, 2025 /PRNewswire/ — Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted... Read more.
Independent Proxy Advisory Firms Recommend Converge Technology Solutions Shareholders Vote For the Proposed Acquisition by an Affiliate of H.I.G. Capital
TORONTO and GATINEAU, QC, March 25, 2025 /PRNewswire/ – Converge Technology Solutions Corp. (“Converge” or the “Company”) (TSX: CTS)... Read more.